UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009236
Receipt number R000010847
Scientific Title Comparison of the effects of raloxifene and bazedoxifene on the health screening results of postmenopausal women
Date of disclosure of the study information 2012/11/01
Last modified on 2018/05/06 09:09:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of the effects of raloxifene and bazedoxifene on the health screening results of postmenopausal women

Acronym

Comparison of the effects of raloxifene and bazedoxifene on the health screening results of postmenopausal women

Scientific Title

Comparison of the effects of raloxifene and bazedoxifene on the health screening results of postmenopausal women

Scientific Title:Acronym

Comparison of the effects of raloxifene and bazedoxifene on the health screening results of postmenopausal women

Region

Japan


Condition

Condition

postmenopausal osteoporosis

Classification by specialty

Endocrinology and Metabolism Obstetrics and Gynecology Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the effects of two types of estrogen agonist-antagonists, raloxifene and bazedoxifene, on health screening results in postemenopausal women diagnosed with postmenopausal osteoporosis

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the results of a health screening program, bone mineral density, bone turnover markers

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

1-year treatment with 60 mg of raloxifene

Interventions/Control_2

1-year treatment with 20 mg of bazedoxifene

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

women diagnosed with postmenopausal osteoporosis

Key exclusion criteria

(1)venous thromboembolism
(2)long-term immobility
(3)antiphospholipid syndrome

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masakazu Terauchi

Organization

Tokyo Medical and Dental University

Division name

Department of Women's Health

Zip code


Address

Yushima 1-5-45, Bunkyo, Tokyo

TEL

03-5803-4605

Email

teragyne@tmd.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masakazu Terauchi

Organization

Tokyo Medical and Dental University

Division name

Department of Women's Health

Zip code


Address

Yushima 1-5-45, Bunkyo, Tokyo

TEL

03-5803-4605

Homepage URL


Email

teragyne@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Tokyo Medical and Dental University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Hitachinaka General Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

ひたちなか総合病院(茨城県)


Other administrative information

Date of disclosure of the study information

2012 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2012 Year 09 Month 11 Day

Date of IRB


Anticipated trial start date

2012 Year 11 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 10 Month 31 Day

Last modified on

2018 Year 05 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010847


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name